BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7907680)

  • 1. Association of dopamine D2 receptor molecular variant with schizophrenia.
    Arinami T; Itokawa M; Enguchi H; Tagaya H; Yano S; Shimizu H; Hamaguchi H; Toru M
    Lancet; 1994 Mar; 343(8899):703-4. PubMed ID: 7907680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
    Chen CH; Chien SH; Hwu HG
    Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
    Kaneshima M; Higa T; Nakamoto H; Nagamine M
    Psychiatry Clin Neurosci; 1997 Dec; 51(6):379-81. PubMed ID: 9472122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
    Higuchi S; Muramatsu T; Murayama M; Hayashida M
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.
    Verga M; Macciardi F; Pedrini S; Cohen S; Smeraldi E
    Schizophr Res; 1997 May; 25(2):117-21. PubMed ID: 9187010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Fukushima N; Takahashi M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Apr; 67(2):208-11. PubMed ID: 8723049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
    Sasaki T; Macciardi FM; Badri F; Verga M; Meltzer HY; Lieberman J; Howard A; Bean G; Joffe RT; Hudson CJ; Kennedy JL
    Am J Med Genet; 1996 Jul; 67(4):415-7. PubMed ID: 8837713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
    Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
    Crawford F; Hoyne J; Cai X; Osborne A; Poston D; Zaglul J; Dajani N; Walsh S; Bradley R; Solomon R; Mullan M
    Am J Med Genet; 1996 Sep; 67(5):483-4. PubMed ID: 8886166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka.
    Harano M
    Kurume Med J; 1997; 44(3):201-8. PubMed ID: 9339651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
    Laurent C; Bodeau-Péan S; Campion D; d'Amato T; Jay M; Dollfus S; Thibault F; Petit M; Samolyk D; Martinez M
    Psychiatr Genet; 1994; 4(4):229-30. PubMed ID: 7712120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Pal H; Saxena S
    Natl Med J India; 1995; 8(3):125-6. PubMed ID: 7780354
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine receptor D2 Ser/Cys311 variant associated with disorganized symptomatology of schizophrenia.
    Serretti A; Macciardi F; Smeraldi E
    Schizophr Res; 1998 Nov; 34(3):207-10. PubMed ID: 9850987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological research on schizophrenia.
    Toru M
    Psychiatry Clin Neurosci; 1998 Dec; 52 Suppl():S170-2. PubMed ID: 9895138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
    Itokawa M; Arinami T; Toru M
    J Pharmacol Sci; 2010; 114(1):1-5. PubMed ID: 20716857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia.
    Hattori M; Nanko S; Dai XY; Fukuda R; Kazamatsuri H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):757-63. PubMed ID: 7914079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.
    Jönsson EG; Sillén A; Vares M; Ekholm B; Terenius L; Sedvall GC
    Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):28-34. PubMed ID: 12707934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Asherson P; Williams N; Roberts E; McGuffin M; Owen M
    Lancet; 1994 Apr; 343(8904):1045. PubMed ID: 7909080
    [No Abstract]   [Full Text] [Related]  

  • 20. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
    Shaikh S; Collier D; Arranz M; Ball D; Gill M; Kerwin R
    Lancet; 1994 Apr; 343(8904):1045-6. PubMed ID: 7909081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.